Astaxanthin nanoemulsion improves cognitive function and synaptic integrity in Streptozotocin-induced Alzheimer’s disease model
- 6 March 2025
- journal article
- research article
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 40 (3) , 1-18
Abstract
Astaxanthin derived from natural sources has excellent antioxidant and anti-inflammatory effects, and it is currently being widely researched as a neuroprotectant. However, astaxanthin possesses low oral bioavailability, and thus, astaxanthin extract from Haematococcus pluvialis was formulated into a nanoemulsion to improve its bioavailability and administered to Alzheimer’s disease (AD)-like rats to study its possible neuroprotective benefits. Astaxanthin nanoemulsion was administered orally once a day for 28 days to streptozotocin (STZ)-induced AD rats at concentrations of 160, 320, and 640 mg/kg of body weight (bw) and subsequently assessed for cognitive function using behavioral assessments. Brain samples were collected for the assessment of AD biomarkers. Astaxanthin nanoemulsion at a dosage of 640 mg/kg bw significantly improved spatial learning, spatial memory, and recognition memory against STZ-AD rats. At 320 and 640 mg/kg bw, astaxanthin nanoemulsion significantly reduced levels of hippocampus synaptosomal amyloid beta and paired-helical fibrillary tau protein while increasing neuron survival. Additionally, astaxanthin nanoemulsion at 640 mg/kg bw significantly increased acetylcholine levels in the hippocampus and cerebellum. Astaxanthin nanoemulsion at all treatment dosages significantly reduced malondialdehyde, a lipid peroxidation product, and neuroinflammatory mediators (GFAP and TNF-α). Astaxanthin nanoemulsion supplementation has the potential to improve cognitive function and synaptic function by lowering amyloid beta and tau levels, as well as preserve neuron integrity by reducing neuroinflammation and lipid peroxidation, indicating that it may be able to treat some of the underlying causes of AD.Keywords
Funding Information
- Ministry of Higher Education, Malaysia (FRGS/1/2019/SKK08/UITM/02/5, FRGS/1/2019/SKK08/UITM/02/5, FRGS/1/2019/SKK08/UITM/02/5, FRGS/1/2019/SKK08/UITM/02/5)
This publication has 63 references indexed in Scilit:
- Intracerebroventricular Streptozotocin Injections as a Model of Alzheimer’s Disease: in Search of a Relevant MechanismMolecular Neurobiology, 2015
- Streptozotocin induced Alzheimer′s disease like changes and the underlying neural degeneration and regeneration mechanismNeural Regeneration Research, 2015
- The novel object recognition memory: neurobiology, test procedure, and its modificationsCognitive Processing, 2011
- Combined fish oil and astaxanthin supplementation modulates rat lymphocyte functionEuropean Journal of Nutrition, 2011
- Post-injury administration of NAAG peptidase inhibitor prodrug, PGI-02776, in experimental TBIBrain Research, 2011
- Astaxanthin Inhibits Glutamate Release in Rat Cerebral Cortex Nerve Terminals via Suppression of Voltage-Dependent Ca2+Entry and Mitogen-Activated Protein Kinase Signaling PathwayJournal of Agricultural and Food Chemistry, 2010
- A rapid Percoll gradient procedure for preparation of synaptosomesNature Protocols, 2008
- Co-Localization of Amyloid Beta and Tau Pathology in Alzheimer's Disease SynaptosomesThe American Journal of Pathology, 2008
- Dose translation from animal to human studies revisitedThe FASEB Journal, 2007
- Cholinergic innervation of the human cerebellumJournal of Comparative Neurology, 1993